9 citations
,
September 2014 in “Cancer Epidemiology, Biomarkers & Prevention” Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.
Monocyclic aromatic compounds are important for developing various drugs and treatments.
14 citations
,
June 1995 in “The Journal of Clinical Endocrinology and Metabolism” 6 citations
,
January 2024 in “Cancers” Antiandrogens don't help with COVID-19 and aren't recommended.
Testosterone undecanoate can reduce the negative effects of Finasteride on male reproductive health.
27 citations
,
March 2017 in “Current Clinical Pharmacology” Dutasteride is becoming a popular hair loss treatment, proving more effective than finasteride with similar side effects.
Finasteride and dutasteride can harm male reproductive health, affecting sperm and causing sexual dysfunction.
August 2025 in “Fabad Journal of Pharmaceutical Sciences” Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.
11 citations
,
May 2010 in “Journal of Medicinal Chemistry” A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.
11 citations
,
January 1991 in “Urology” New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.
June 2014 in “Reactions Weekly” August 2011 in “Reactions Weekly” January 2014 in “Reactions Weekly” December 2024 in “Reactions Weekly” November 2014 in “Reactions Weekly” July 2014 in “Reactions Weekly” August 2013 in “Reactions Weekly” January 2013 in “Reactions Weekly” December 2012 in “Reactions Weekly” August 2012 in “Reactions Weekly” May 2011 in “Reactions Weekly” April 2011 in “Reactions Weekly” March 2011 in “Reactions Weekly” April 2010 in “Reactions Weekly” October 2008 in “Reactions Weekly” October 2008 in “Reactions Weekly” February 2008 in “Reactions Weekly” November 2007 in “Reactions Weekly” January 2004 in “Reactions Weekly” March 2003 in “Reactions Weekly”